Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Norbert Graf

Showing results (281-290 of 318) with videos related to

Pageof 32
Sort By:
Nature Reviews. Urology|November 2, 2017
Position paper: Rationale for the treatment of Wilms tumour in the UMBRELLA SIOP-RTSG 2016 protocolMarry M van den Heuvel-Eibrink, Janna A Hol, Kathy Pritchard-Jones, et al.
JCO Precision Oncology|May 18, 2026
Systematic Review: Prognostic Molecular Biomarkers in Wilms TumorsAgustina Oller, Patrick Kemmeren, Daniela Perotti, et al.
Cancer|November 4, 2020
Clinical characteristics and outcomes of children with WAGR syndrome and Wilms tumor and/or nephroblastomatosis: The 30-year SIOP-RTSG experienceJanna A Hol, Marjolijn C J Jongmans, Hélène Sudour-Bonnange, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 29, 2025
Late toxicity after upper abdominal radiotherapy in pediatric Wilms tumor and neuroblastoma survivors. A systematic review on behalf of SIOPEN and SIOP-RTSGFrancis S P L Wens, Federica Zonca, Harm van Tinteren, et al.
Urologic Oncology|June 22, 2025
Outcome of patients with a first relapse after intermediate- or high-risk Wilms tumor, treated according to SIOP WT 2001/UK-IMPORT study; A report from the SIOP renal tumor study groupAlissa Groenendijk, Harm van Tinteren, Ronald R de Krijger, et al.
Nature Communications|June 20, 2018
Recurrent intragenic rearrangements of EGFR and BRAF in soft tissue tumors of infantsJenny Wegert, Christian Vokuhl, Grace Collord, et al.
JCO Clinical Cancer Informatics|June 23, 2026
A Harmonized International Database of More Than 10,000 Pediatric Renal Tumor Patients From 30 Years of SIOP-RTSG StudiesPrakriti Roy, Ingrid Schut, Norbert Graf, et al.
European Journal of Cancer (Oxford, England : 1990)|January 18, 2022
Outcome of SIOP patients with low- or intermediate-risk Wilms tumour relapsing after initial vincristine and actinomycin-D therapy only - the SIOP 93-01 and 2001 protocolsAlissa Groenendijk, Harm van Tinteren, Yilin Jiang, et al.
Clinical and Translational Radiation Oncology|April 2, 2021
Inter-clinician delineation variation for a new highly-conformal flank target volume in children with renal tumors: A SIOP-Renal Tumor Study Group international multicenter exerciseJoeri Mul, Patrick Melchior, Enrica Seravalli, et al.
International Journal of Cancer|January 30, 2019
TRIM28 haploinsufficiency predisposes to Wilms tumorIllja J Diets, Juliane Hoyer, Arif B Ekici, et al.
Pageof 32

Showing results (281-290 of 318) with videos related to

Sort By:
Pageof 32
Nature Reviews. Urology|November 2, 2017
Position paper: Rationale for the treatment of Wilms tumour in the UMBRELLA SIOP-RTSG 2016 protocolMarry M van den Heuvel-Eibrink, Janna A Hol, Kathy Pritchard-Jones, et al.
JCO Precision Oncology|May 18, 2026
Systematic Review: Prognostic Molecular Biomarkers in Wilms TumorsAgustina Oller, Patrick Kemmeren, Daniela Perotti, et al.
Cancer|November 4, 2020
Clinical characteristics and outcomes of children with WAGR syndrome and Wilms tumor and/or nephroblastomatosis: The 30-year SIOP-RTSG experienceJanna A Hol, Marjolijn C J Jongmans, Hélène Sudour-Bonnange, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 29, 2025
Late toxicity after upper abdominal radiotherapy in pediatric Wilms tumor and neuroblastoma survivors. A systematic review on behalf of SIOPEN and SIOP-RTSGFrancis S P L Wens, Federica Zonca, Harm van Tinteren, et al.
Urologic Oncology|June 22, 2025
Outcome of patients with a first relapse after intermediate- or high-risk Wilms tumor, treated according to SIOP WT 2001/UK-IMPORT study; A report from the SIOP renal tumor study groupAlissa Groenendijk, Harm van Tinteren, Ronald R de Krijger, et al.
Nature Communications|June 20, 2018
Recurrent intragenic rearrangements of EGFR and BRAF in soft tissue tumors of infantsJenny Wegert, Christian Vokuhl, Grace Collord, et al.
JCO Clinical Cancer Informatics|June 23, 2026
A Harmonized International Database of More Than 10,000 Pediatric Renal Tumor Patients From 30 Years of SIOP-RTSG StudiesPrakriti Roy, Ingrid Schut, Norbert Graf, et al.
European Journal of Cancer (Oxford, England : 1990)|January 18, 2022
Outcome of SIOP patients with low- or intermediate-risk Wilms tumour relapsing after initial vincristine and actinomycin-D therapy only - the SIOP 93-01 and 2001 protocolsAlissa Groenendijk, Harm van Tinteren, Yilin Jiang, et al.
Clinical and Translational Radiation Oncology|April 2, 2021
Inter-clinician delineation variation for a new highly-conformal flank target volume in children with renal tumors: A SIOP-Renal Tumor Study Group international multicenter exerciseJoeri Mul, Patrick Melchior, Enrica Seravalli, et al.
International Journal of Cancer|January 30, 2019
TRIM28 haploinsufficiency predisposes to Wilms tumorIllja J Diets, Juliane Hoyer, Arif B Ekici, et al.
Pageof 32